186 related articles for article (PubMed ID: 26210443)
1. Effect of Irradiation on Incidence of Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation in Miniature Swine.
Matar AJ; Patil AR; Al-Musa A; Hanekamp I; Sachs DH; Huang CA; Duran-Struuck R
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1732-8. PubMed ID: 26210443
[TBL] [Abstract][Full Text] [Related]
2. High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment.
Juvonen E; Aalto SM; Tarkkanen J; Volin L; Mattila PS; Knuutila S; Ruutu T; Hedman K
Bone Marrow Transplant; 2003 Jul; 32(1):97-102. PubMed ID: 12815484
[TBL] [Abstract][Full Text] [Related]
3. Posttransplantation lymphoproliferative disease in miniature swine after allogeneic hematopoietic cell transplantation: similarity to human PTLD and association with a porcine gammaherpesvirus.
Huang CA; Fuchimoto Y; Gleit ZL; Ericsson T; Griesemer A; Scheier-Dolberg R; Melendy E; Kitamura H; Fishman JA; Ferry JA; Harris NL; Patience C; Sachs DH
Blood; 2001 Mar; 97(5):1467-73. PubMed ID: 11222395
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for the development of post-transplant lymphoproliferative disorder in a large animal model.
Cho PS; Mueller NJ; Cameron AM; Cina RA; Coburn RC; Hettiaratchy S; Melendy E; Neville DM; Patience C; Fishman JA; Sachs DH; Huang CA
Am J Transplant; 2004 Aug; 4(8):1274-82. PubMed ID: 15268728
[TBL] [Abstract][Full Text] [Related]
5. High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts.
Hoegh-Petersen M; Goodyear D; Geddes MN; Liu S; Ugarte-Torres A; Liu Y; Walker JT; Fonseca K; Daly A; Duggan P; Stewart D; Russell JA; Storek J
Bone Marrow Transplant; 2011 Aug; 46(8):1104-12. PubMed ID: 21057556
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for post-transplant lymphoproliferative disorder after Thymoglobulin-conditioned hematopoietic cell transplantation.
Kalra A; Roessner C; Jupp J; Williamson T; Tellier R; Chaudhry A; Khan F; Taparia M; Jimenez-Zepeda VH; Stewart DA; Daly A; Storek J
Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29114932
[TBL] [Abstract][Full Text] [Related]
7. Post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation: a single-center experience.
Luo L; Zhang L; Cai B; Li H; Huang W; Jing Y; Zhu H; Zhao Y; Bo J; Wang Q; Han X; Yu L; Gao C
Ann Transplant; 2014 Jan; 19():6-12. PubMed ID: 24399278
[TBL] [Abstract][Full Text] [Related]
8. Post-transplantation lymphoproliferative disorder of recipient origin in a boy with acute T-cell leukemia with detection of B-cell clonality 3 months before stem cell transplantation.
Kontny U; Boppana S; Jung A; Goebel H; Strahm B; Peters A; Dormann S; Werner M; Bader P; Fisch P; Niemeyer C
Haematologica; 2005 Nov; 90 Suppl():ECR27. PubMed ID: 16266918
[TBL] [Abstract][Full Text] [Related]
9. CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.
Rabot N; Büchler M; Foucher Y; Moreau A; Debiais C; Machet MC; Kessler M; Morelon E; Thierry A; Legendre C; Rivalan J; Kamar N; Dantal J
Transpl Int; 2014 Sep; 27(9):956-65. PubMed ID: 24964147
[TBL] [Abstract][Full Text] [Related]
10. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
11. Posttransplant lymphoproliferative disease after allogeneic transplantation of the spleen in miniature swine.
Dor FJ; Doucette KE; Mueller NJ; Wilkinson RA; Bajwa JA; McMorrow IM; Tseng YL; Kuwaki K; Houser SL; Fishman JA; Cooper DK; Huang CA
Transplantation; 2004 Jul; 78(2):286-91. PubMed ID: 15280692
[TBL] [Abstract][Full Text] [Related]
12. Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients.
Manlhiot C; Pollock-Barziv SM; Holmes C; Weitzman S; Allen U; Clarizia NA; Ngan BY; McCrindle BW; Dipchand AI
J Heart Lung Transplant; 2010 Jun; 29(6):648-57. PubMed ID: 20304682
[TBL] [Abstract][Full Text] [Related]
13. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
14. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
15. Post-transplant lymphoproliferative disorder: a review.
Loren AW; Porter DL; Stadtmauer EA; Tsai DE
Bone Marrow Transplant; 2003 Feb; 31(3):145-55. PubMed ID: 12621474
[TBL] [Abstract][Full Text] [Related]
16. Unmanipulated donor lymphocytes for EBV-related PTLD after T-cell depleted HLA-haploidentical transplantation.
De Pasquale MD; Mastronuzzi A; De Vito R; Cometa A; Inserra A; Russo C; De Ioris MA; Locatelli F
Pediatrics; 2012 Jan; 129(1):e189-94. PubMed ID: 22144701
[TBL] [Abstract][Full Text] [Related]
17. Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage.
Crane GM; Powell H; Kostadinov R; Rocafort PT; Rifkin DE; Burger PC; Ambinder RF; Swinnen LJ; Borowitz MJ; Duffield AS
Oncotarget; 2015 Oct; 6(32):33849-66. PubMed ID: 26460822
[TBL] [Abstract][Full Text] [Related]
18. Posttransplant Lymphoproliferative Disorder in Solid Organ and Hematopoietic Stem Cell Transplantation.
Nagle SJ; Reshef R; Tsai DE
Clin Chest Med; 2017 Dec; 38(4):771-783. PubMed ID: 29128025
[TBL] [Abstract][Full Text] [Related]
19. Effect of in vivo lymphocyte-depleting strategies on development of lymphoproliferative disorders in children post allogeneic bone marrow transplantation.
Lynch BA; Vasef MA; Comito M; Gilman AL; Lee N; Ritchie J; Rumelhart S; Holida M; Goldman F
Bone Marrow Transplant; 2003 Sep; 32(5):527-33. PubMed ID: 12942101
[TBL] [Abstract][Full Text] [Related]
20. Malignancies after hematopoietic stem cell transplantation: many questions, some answers.
Deeg HJ; Socie G
Blood; 1998 Mar; 91(6):1833-44. PubMed ID: 9490664
[No Abstract] [Full Text] [Related]
[Next] [New Search]
